Trial Profile
The effects of sitagliptin (Januvia) on myocardial performance in patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics
- 22 Dec 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-000300-89).
- 09 Aug 2008 New trial record.